www.lowdosenaltrexone.org www.ldninfo.org

The Third Annual LDN Conference (2007)

Updated: Mar 9, 2008



Breaking Down Barriers

The Third Annual LDN Conference

October 20, 2007 — Vanderbilt University
Nashville, Tennessee

Post-Conference Report & Multimedia



2007 Post-Conference Report

With a full-capacity attendance of 130, the Third Annual Low Dose Naltrexone Conference was held on Saturday, October 20th in the Student Life Center of Vanderbilt University in Nashville, Tennessee. The conference theme, "Breaking Down Barriers", underscored the quantum leap in the number of research centers at which trials of LDN have been implemented within the past year.

Many thanks to all of the donors who supported the conference and enabled the forgoing of any registration fee. Major financial support was received from both Victor Falah of Irmat Pharmacy and Skip Lenz of Skip’s Pharmacy. Sincere thanks also to Cyndi Lenz and Adam Lenz who videotaped and photographed the entire conference, providing the multimedia files accessed through this webpage.



2007 Conference Multimedia




Multimedia Notes:
  1. Video clips below are in QuickTime format. If you have any difficulty in viewing a clip, please download the latest version of Quicktime. If you cannot view the video within your browser, try running QuickTime itself and using the "File | Open URL..." command (you will need to copy the video link from this page and paste it into QuickTime's Open URL dialogue box). Please be patient as each video takes time to download.
  2. Slides, for easier viewing within your browser, have also been posted in Quicktime (movie) format. When viewing a slideshow, press pause to stop and read a particular slide, play to continue (pause will usually appear as 2 vertical bars in the lower left of the video window).
  3. Please note that in some cases, audio/video recording of particular speakers was incomplete.

View the 2007 conference trailer...

Following are the speakers in the order of their presentations:

  • Coordinators Brenda Powell and Sunny Sedlock: Welcome

    Audio

    Video

  • David Gluck, MD: Overview of a “tipping point” year, with updates on 6 current clinical trials of LDN

    Audio

    Video

  • Jill Smith, MD: Progress report—the Phase II trial of LDN for Crohn’s disease at Pennsylvania State University [Editor's Note: Dr. Smith's presentation was not recorded at her request because the data in her presentation is pending publication.]


  • Burt Berkson, MD: Private practice experiences with LDN for cancers and autoimmune diseases

    Audio

    Video

    Slides

  • Terry Grossman, MD: Medical approaches, including LDN, for stage IV renal cancer

    Audio

    Video

  • Dr. Skip Lenz: A pharmacy’s survey of treatment outcomes in 248 patients using LDN for multiple sclerosis

    Audio

    Video

    Slides

  • Dr. Pat Crowley: Practitioner in Ireland—50 patients on LDN for multiple sclerosis

    Audio

    Video

  • Dr. Brendan Quinn: Pharmacist from county Galway reports main local uses of LDN

    Audio

    Video

  • Dr. Tom Gilhooly: Planned trial in Scotland on urological effects of LDN in MS (unable to attend; paper read)

    Audio

    Video

  • Dr. Jaquelyn McCandless: LDN for Autism and details on the new study in Mali of LDN for HIV (unable to attend; materials presented)

    Audio

    Video

    Slides

  • Dr. David Gluck and Conference Attendees: Attendee commentary, Q&A, and Dr. Gluck's closing remarks

    Audio

    Video